Leigh Anderson has been appointed to the scientific advisory board of biOasis Technologies, the company said this week.
Anderson is the founder and CEO of the Plasma Proteome Institute, and was chief scientific officer at Large Scale Biology, where he founded the proteomics division in 1985. LSB merged with Biosource Technologies in 1999.
biOasis, based in British Columbia, develops and commercializes diagnostics and therapeutics for neurological diseases.